YouTube Facebook LinkedIn Google+ Twitter Xingrss  


Covance, Pathoquest Collaborate on NGS Safety Platform



November 7, 2013 | Covance and Pathoquest have signed an agreement to build an NGS-based biosafety assessment platform. The platform would detect contaminants within monoclonal antibodies or vaccines. Outsourcing Pharma
Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.